Vertero Therapeutics

Waltham, Massachusetts, United States · Biotechnology, Health Care · 35 employees

Vertero Therapeutics is pioneering science beyond the brain to treat neurodegenerative diseases at their source. Vertero’s development pipeline of differentiated therapies targets the peripheral nervous system to delay onset and slow progression of challenging conditions such as Parkinson’s disease. The company's lead program, VT-5006, is designed to precisely treat a validated target in the gut t

See plans & pricing → Track Vertero Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.